202 related articles for article (PubMed ID: 10367549)
1. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.
Comer SD; Collins ED; MacArthur RB; Fischman MW
Psychopharmacology (Berl); 1999 Apr; 143(4):327-38. PubMed ID: 10367549
[TBL] [Abstract][Full Text] [Related]
2. Effects of an alternative reinforcer on intravenous heroin self-administration by humans.
Comer SD; Collins ED; Wilson ST; Donovan MR; Foltin RW; Fischman MW
Eur J Pharmacol; 1998 Mar; 345(1):13-26. PubMed ID: 9593589
[TBL] [Abstract][Full Text] [Related]
3. Choice between money and intranasal heroin in morphine-maintained humans.
Comer SD; Collins ED; Fischman MW
Behav Pharmacol; 1997 Dec; 8(8):677-90. PubMed ID: 9832953
[TBL] [Abstract][Full Text] [Related]
4. Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.
Sullivan MA; Vosburg SK; Comer SD
Psychopharmacology (Berl); 2006 Nov; 189(1):37-46. PubMed ID: 16972105
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
Comer SD; Walker EA; Collins ED
Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
[TBL] [Abstract][Full Text] [Related]
6. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.
Comer SD; Sullivan MA; Whittington RA; Vosburg SK; Kowalczyk WJ
Neuropsychopharmacology; 2008 Apr; 33(5):1179-91. PubMed ID: 17581533
[TBL] [Abstract][Full Text] [Related]
7. Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers.
Comer SD; Sullivan MA
Psychopharmacology (Berl); 2007 Aug; 193(2):235-45. PubMed ID: 17406858
[TBL] [Abstract][Full Text] [Related]
8. Intravenous buprenorphine self-administration by detoxified heroin abusers.
Comer SD; Collins ED; Fischman MW
J Pharmacol Exp Ther; 2002 Apr; 301(1):266-76. PubMed ID: 11907183
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals.
Comer SD; Sullivan MA; Walker EA
J Pharmacol Exp Ther; 2005 Dec; 315(3):1320-30. PubMed ID: 16144974
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration.
Skopp G; Ganssmann B; Cone EJ; Aderjan R
J Anal Toxicol; 1997; 21(2):105-11. PubMed ID: 9083827
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.
Comer SD; Collins ED; Fischman MW
Psychopharmacology (Berl); 2001 Feb; 154(1):28-37. PubMed ID: 11292003
[TBL] [Abstract][Full Text] [Related]
12. The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users.
Jones JD; Madera G; Comer SD
Pharmacol Biochem Behav; 2014 Jul; 122():299-306. PubMed ID: 24793093
[TBL] [Abstract][Full Text] [Related]
13. Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats.
Solinas M; Panlilio LV; Goldberg SR
Neuropsychopharmacology; 2004 Jul; 29(7):1301-11. PubMed ID: 15039767
[TBL] [Abstract][Full Text] [Related]
14. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.
Comer SD; Collins ED
J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
Smith ML; Shimomura ET; Summers J; Paul BD; Jenkins AJ; Darwin WD; Cone EJ
J Anal Toxicol; 2001 Oct; 25(7):504-14. PubMed ID: 11599592
[TBL] [Abstract][Full Text] [Related]
16. Chronic opioid exposure produces increased heroin self-administration in rats.
Walker JR; Chen SA; Moffitt H; Inturrisi CE; Koob GF
Pharmacol Biochem Behav; 2003 May; 75(2):349-54. PubMed ID: 12873626
[TBL] [Abstract][Full Text] [Related]
17. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
[TBL] [Abstract][Full Text] [Related]
18. Heroin self-administration by means of 'chasing the dragon': pharmacodynamics and bioavailability of inhaled heroin.
Hendriks VM; van den Brink W; Blanken P; Bosman IJ; van Ree JM
Eur Neuropsychopharmacol; 2001 Jun; 11(3):241-52. PubMed ID: 11418285
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
[TBL] [Abstract][Full Text] [Related]
20. High levels of morphine-6-glucuronide in street heroin addicts.
Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
